๐Ÿšš Ships in 24โ€“72 hrs ยท Free U.S. shipping $50+

๐Ÿ“ฆ Discreet packaging ยท Shipped Securely

๐Ÿ’ณ Pay later with Shop Pay, Sezzle & Afterpay

GLP-1 Dosage Explained for Beginners: Starting Doses, Titration & What to Expect

Woman examining GLP-1 medication vial at home with telehealth setup, representing compounded semaglutide safety and proper medical use
By HauteFlair Editors May 5, 2026 10 min read Women's Health & GLP-1
๐Ÿฉบ Reviewed by a licensed medical provider ย |ย  Last updated May 2026
GLP-1 dosage is not a single number โ€” it is a carefully structured progression designed to let your body adapt while building toward the dose that produces results. Most people start far lower than they expect, increase slowly over several months, and find that the right dose for them is not necessarily the maximum possible dose. This guide explains the entire dosage picture โ€” what you start on, how increases work, what each level typically feels like, and how your provider makes dosing decisions throughout your treatment.
Provider-Managed Dosing โ€” Every Step of the Way

ElixMD: GLP-1 Dosing Managed by Licensed Providers

Your dose is not set-and-forget. Monthly check-ins with board-certified providers adjust your dose based on your progress, your tolerability, and your goals โ€” from your first 0.25mg to your maintenance dose.

Start My GLP-1 Journey at ElixMD โ†’
โœฆ Quick Answer โ€” GLP-1 Dosage Basics
  • Semaglutide starts at 0.25mg/week โ€” well below the therapeutic dose โ€” to minimize side effects.
  • Doses increase every 4 weeks: 0.25mg โ†’ 0.5mg โ†’ 1mg โ†’ 1.7mg โ†’ 2.4mg (max).
  • Tirzepatide starts at 2.5mg/week, increasing to a maximum of 15mg.
  • Your provider controls dose increases at monthly check-ins โ€” you do not self-escalate.
  • Many women find their effective dose at 1mg or 1.7mg and never need the maximum.
0.25mg the standard starting dose for semaglutide โ€” one-tenth of the maximum, designed to let your body adjust gradually
4 weeks the minimum time at each dose level before a provider considers an increase โ€” no rushing the titration
2.4mg the maximum approved semaglutide dose โ€” but most women find their effective dose before reaching it

Why GLP-1 Dosing Works the Way It Does

The gradual titration approach is not arbitrary โ€” it exists for two distinct clinical reasons that directly affect your experience and your results.

The Clinical Logic

Why You Start Low and Go Slow

  • Side effect management: GLP-1 medications act on receptors in the gut, the brain, and the pancreas simultaneously. Introducing a full therapeutic dose immediately overwhelms these systems and produces severe nausea, vomiting, and GI distress in most people. The gradual approach allows your GI system to adapt โ€” most people find side effects significantly diminished by week four to eight as their body adjusts to each dose level.
  • Finding your minimum effective dose: more is not always better with GLP-1. The goal is the lowest dose that produces meaningful results with acceptable side effects โ€” not the highest dose possible. The titration schedule allows your provider to identify where you sit on that curve. Many women produce excellent results at 1mg and have no clinical reason to escalate to 2.4mg.
  • Building the habit: the titration period โ€” three to four months of weekly injections at increasing doses โ€” builds the injection routine, the dietary adjustments, and the provider relationship that support your full treatment period. It is not just a dose escalation; it is an onboarding process.

The Semaglutide Dosage Ladder โ€” Step by Step

The standard semaglutide titration schedule moves through five dose levels. Each level serves a distinct clinical purpose. Here is what each step looks like, what to expect at each level, and the timing between increases.

SEMAGLUTIDE TITRATION SCHEDULE โ€” STANDARD PROTOCOL
0.25 mg/week
Starting Dose โ€” Weeks 1โ€“4 Not a therapeutic dose โ€” this level is purely about tolerability. Most women feel minimal appetite suppression at 0.25mg, but side effects are also typically minimal. This is the adjustment phase. Do not judge the medication's effectiveness from this level.
Weeks
1โ€“4
0.5 mg/week
First Increase โ€” Weeks 5โ€“8 The first meaningful therapeutic level. Most women begin to notice genuine appetite suppression at 0.5mg. Some nausea is common at this transition but typically resolves within 7โ€“10 days. Early weight loss โ€” usually 2โ€“5 lbs โ€” begins to become visible at this level.
Weeks
5โ€“8
1.0 mg/week
Standard Therapeutic Dose โ€” Weeks 9โ€“12 This is where most women find a significant and consistent effect. Many providers keep patients at 1mg for extended periods if results are good. Clinical trials show meaningful weight loss at this level. A significant subset of women do not need to go higher.
Weeks
9โ€“12
1.7 mg/week
Higher Therapeutic Dose โ€” Weeks 13โ€“16 Introduced when the clinical picture supports escalation โ€” either for increased efficacy or because 1mg has produced a plateau. Effects at 1.7mg are meaningfully stronger than at 1mg for most women. Side effects can intensify with this increase โ€” especially GI symptoms in the first 1โ€“2 weeks.
Weeks
13โ€“16
2.4 mg/week
Maximum Dose โ€” Week 17+ The highest approved dose for weight loss. Produces the strongest appetite suppression and the greatest clinical weight loss outcomes on average. Not everyone reaches this level โ€” it is only clinically justified if lower doses are producing inadequate results and side effects are manageable.
Week
17+
โœฆ The Dose That's Right for You

The titration schedule is a framework โ€” not a mandate. Many women on semaglutide remain at 1mg or 1.7mg throughout their treatment because that is their minimum effective dose. Your provider's goal is not to get you to 2.4mg โ€” it is to find the dose that produces meaningful results with acceptable side effects. If 1mg works well for you, staying there is a clinically sound decision.

The Tirzepatide Dosage Ladder

Tirzepatide (compounded or brand-name Zepbound/Mounjaro) uses a different dose scale than semaglutide โ€” larger numbers, different receptor mechanism, and generally stronger clinical outcomes at equivalent positions in the titration schedule.

TIRZEPATIDE TITRATION SCHEDULE โ€” STANDARD PROTOCOL
2.5 mg/week
Starting Dose โ€” Weeks 1โ€“4 Adjustment phase. Minimal therapeutic effect expected โ€” purely about tolerability. Tirzepatide acts on both GLP-1 and GIP receptors, so the adjustment period is important for the dual-receptor system to adapt.
Weeks
1โ€“4
5 mg/week
First Therapeutic Level โ€” Weeks 5โ€“8 Many women notice significant appetite suppression beginning at 5mg. Clinical trial data shows meaningful weight loss at this level โ€” more than comparable semaglutide doses at equivalent positions in the titration schedule.
Weeks
5โ€“8
7.5 mg/week
Standard Therapeutic โ€” Weeks 9โ€“12 Consistent, strong appetite suppression. A significant proportion of women in the SURMOUNT-1 trial achieved their maximum weight loss on doses of 10mg or less โ€” many at 7.5mg specifically.
Weeks
9โ€“12
10 mg/week
Higher Dose โ€” Weeks 13โ€“16 Escalation indicated when lower levels have produced plateaus or inadequate results. Average weight loss in SURMOUNT-1 at 10mg: approximately 19.5% of body weight over 72 weeks.
Weeks
13โ€“16
12.5 mg/week
Pre-Maximum Dose โ€” Weeks 17โ€“20 Penultimate dose level. Reserved for women who have tolerated lower doses well and require additional efficacy. Strong appetite suppression and consistently strong clinical outcomes in trial data.
Weeks
17โ€“20
15 mg/week
Maximum Dose โ€” Week 21+ Highest approved dose. Average weight loss in SURMOUNT-1 at 15mg: approximately 22.5% of body weight over 72 weeks โ€” the strongest clinical outcome of any approved GLP-1 medication.
Week
21+

Semaglutide vs. Tirzepatide โ€” Dosage Comparison at a Glance

Factor Semaglutide Tirzepatide
Starting dose 0.25mg/week 2.5mg/week
Maximum dose 2.4mg/week 15mg/week
Number of dose levels 5 (0.25 โ†’ 0.5 โ†’ 1 โ†’ 1.7 โ†’ 2.4) 6 (2.5 โ†’ 5 โ†’ 7.5 โ†’ 10 โ†’ 12.5 โ†’ 15)
Time to reach max dose ~17 weeks (if tolerated) ~21 weeks (if tolerated)
Receptor mechanism GLP-1 receptor agonist only GLP-1 + GIP dual receptor agonist
Average weight loss (max dose) ~15% body weight ~22% body weight
Injection frequency Once weekly Once weekly
Which medication and dose is right for you? ElixMD's licensed providers assess your health profile and match you to the right medication and starting dose โ€” semaglutide or tirzepatide.
Find My Right Dose at ElixMD โ†’

How Your Provider Makes Dose Increase Decisions

Dose increases are clinical decisions โ€” not automatic events on a calendar. At each monthly check-in, your provider weighs several factors before recommending an increase, staying at the current dose, or in some cases, stepping back down.

The Dose Decision Framework

What Your Provider Is Evaluating at Each Check-in

  • Side effect severity and frequency: mild, occasional nausea that resolves within a week of each injection is expected and manageable. Persistent vomiting, severe nausea that affects quality of life, or significant GI distress is a signal to hold the current dose โ€” or step back.
  • Progress toward goal: if you are losing weight consistently at the current dose, there is no clinical imperative to increase. The minimum effective dose principle applies โ€” if 0.5mg is producing results, your provider may hold there rather than increase routinely.
  • Plateau assessment: if weight loss has stalled for 4+ weeks at a given dose and side effects are well-managed, an increase is typically the next clinical step.
  • Time at current dose: most providers will not increase before 4 weeks at the current level โ€” your body needs this time to adapt before the assessment of whether the current dose is working or not is meaningful.
  • Your preferences and circumstances: some women prefer to titrate slowly โ€” tolerating a longer timeline at each level to minimize side effects. Others prefer to reach therapeutic doses more quickly. Your provider should be taking your preferences into account alongside the clinical picture.

What Each Dose Level Actually Feels Like

Understanding the subjective experience of each dose level helps you calibrate expectations and communicate clearly with your provider at check-ins. Individual variation is significant, but these patterns are consistent enough to be useful.

0.25mg โ€” The Starting Dose

What Most Women Experience at the Beginning

Appetite suppression is usually subtle or absent at this level โ€” this is intentional. Most women feel the injection is "not doing much" at 0.25mg, which is exactly the right expectation. What is happening is GI adaptation. Side effects, if they occur, are typically mild: slight nausea for a day or two after injection, possibly some fatigue. For most women, this level passes without significant disruption.

0.5mg โ€” First Effects

When Most Women First Notice Something Different

This is typically the level where GLP-1 first feels "real." Appetite suppression becomes noticeable โ€” meals feel satisfying with smaller portions, the constant background of hunger that many women have lived with for years begins to quiet. Nausea can intensify briefly at this transition. The first noticeable weight changes typically appear here โ€” usually 2โ€“5 lbs in the first four weeks at 0.5mg.

1mg โ€” Standard Therapeutic

Where Consistent Results Begin for Most Women

Consistent, meaningful appetite suppression. Food cravings โ€” particularly for high-fat, high-sugar foods โ€” are noticeably reduced for most women at this level. Weight loss becomes more consistent and measurable week to week. Many women find the 1mg level well-tolerated with manageable side effects and good results โ€” and their providers recommend staying here rather than increasing unnecessarily.

1.7mg and 2.4mg โ€” Higher Doses

Stronger Effects With Increased Side Effect Risk

At higher doses, appetite suppression intensifies โ€” some women describe eating becoming genuinely effortless in terms of portion control. Weight loss rates often accelerate briefly after each increase before plateauing at the new level. The trade-off: GI side effects are more pronounced at higher doses, particularly in the first 1โ€“2 weeks after each increase. Muscle preservation becomes more important at higher doses because the appetite suppression is so strong that protein intake can become inadequate without deliberate attention.

"The most common dosing mistake is rushing to the highest dose. The most effective dose is the lowest one that produces meaningful results โ€” because it is also the dose you can sustain, tolerate, and build habits around for the long term."

โ€” HauteFlair Women's Health Editorial Team

Important Dosing Rules Every Beginner Should Know

Non-Negotiable Dosing Rules

What to Always and Never Do With Your GLP-1 Dose

  • Never self-escalate: do not increase your dose without your provider's approval at a check-in. Unsupervised dose increases increase side effect risk and bypass the clinical assessment that makes dose escalation safe.
  • Never double dose after a missed injection: if you miss your weekly injection, follow the missed dose protocol (see FAQ below) โ€” never inject twice the dose to compensate.
  • Do not skip the titration: attempting to start at a higher dose because you want faster results is a reliable way to produce severe nausea and GI distress. The titration schedule exists specifically to prevent this.
  • Store correctly: unopened vials in the refrigerator at 36โ€“46ยฐF. In-use vials can be kept at room temperature (up to 77ยฐF) for up to 28 days. Never freeze.
  • Rotate injection sites: use the same general area (abdomen is most common) but move at least 1 inch from the previous site each week. Consistent injection into the same spot causes local reactions and affects absorption.
  • Inject on the same day each week: consistency in timing maintains stable drug levels and makes it easier to correlate any symptoms with injection timing.
โš  When to Contact Your Provider Immediately

Contact your provider before your next scheduled check-in if you experience: severe vomiting that prevents you from keeping fluids down, severe abdominal pain (not typical nausea), vision changes, rapid heartbeat, or significant allergic reaction symptoms after injection. These are not expected side effects โ€” they warrant clinical evaluation, not waiting for the monthly check-in.

What This Means for You

The most important dosing concept for a GLP-1 beginner is this: the starting dose is not meant to work, and the maximum dose is not the goal. What matters is finding your minimum effective dose โ€” the level that produces meaningful appetite suppression and weight loss with side effects that are manageable enough to sustain long-term treatment.

That dose is different for every woman. Some find it at 0.5mg. Most find it between 1mg and 1.7mg. A smaller subset requires the maximum 2.4mg for maximum benefit. Your provider's job โ€” at every monthly check-in โ€” is to determine where you sit on that curve and adjust accordingly.

If you have not started yet, your titration begins from the moment your first dose arrives. Four weeks from now, you will have a real clinical data point about how your body responds. That is the foundation on which every subsequent decision is built.

Frequently Asked Questions

What is the starting dose of semaglutide for weight loss?
The standard starting dose is 0.25mg per week, injected subcutaneously once weekly. This is well below the therapeutic dose and is designed to minimize side effects during the adjustment period. Most providers maintain this starting dose for 4 weeks before the first increase to 0.5mg. Do not expect significant appetite suppression or weight loss at 0.25mg โ€” that is not its purpose.
How does the GLP-1 titration schedule work?
Titration means gradually increasing your dose at defined intervals. For semaglutide, the standard schedule is: 0.25mg (weeks 1โ€“4), 0.5mg (weeks 5โ€“8), 1mg (weeks 9โ€“12), 1.7mg (weeks 13โ€“16), and 2.4mg maximum (week 17+). Your provider may slow this schedule if you experience significant side effects, hold you at a productive lower dose, or skip a level if clinically indicated. You do not self-manage dose increases.
What is the maximum dose of semaglutide?
The maximum approved dose for weight loss (Wegovy) is 2.4mg per week. For type 2 diabetes (Ozempic), the maximum is 2mg per week. Not everyone reaches the maximum โ€” many women achieve excellent results at 1mg or 1.7mg and have no clinical reason to escalate further. The goal is your minimum effective dose, not the maximum available dose.
What is the starting dose of tirzepatide?
The standard starting dose of tirzepatide is 2.5mg per week for the first 4 weeks, followed by an increase to 5mg for weeks 5โ€“8. Subsequent increases proceed to 7.5mg, 10mg, 12.5mg, and a maximum of 15mg at 4-week intervals based on tolerability. Despite the larger-sounding numbers, tirzepatide uses a different molecular scale than semaglutide โ€” the doses are not directly comparable.
How does my provider decide when to increase my GLP-1 dose?
Dose increase decisions at monthly check-ins are based on: your tolerability at the current dose (side effect severity and frequency), your progress toward your weight loss goal, whether you have been at the current dose for the minimum 4-week period, and whether a plateau has occurred. Your provider may delay an increase if side effects are significant, hold at a productive lower dose, or recommend an increase if you have plateaued and are tolerating the current dose well.
Can I stay at a lower GLP-1 dose indefinitely?
Yes. The titration schedule is a framework, not a requirement to reach the maximum dose. If you are experiencing meaningful results with manageable side effects at 0.5mg, 1mg, or 1.7mg, staying at that dose is clinically sound. Your provider's goal is your minimum effective dose โ€” the level that produces results you can sustain, not the highest dose technically available.
What happens if I miss a dose?
If fewer than 5 days have passed since your missed dose day โ€” inject as soon as you remember, then resume your regular weekly schedule from that new day. If more than 5 days have passed โ€” skip the missed dose entirely and inject on your next regular scheduled day. Never inject double the dose to compensate for a missed injection. If you miss two consecutive weekly doses, contact your provider before resuming.

This article is for informational purposes only and does not constitute medical advice. All dosing decisions โ€” including starting dose, escalation schedule, and maintenance dose โ€” must be made by a licensed provider based on your individual health profile and clinical response. Never self-adjust your GLP-1 dose without provider guidance. ElixMD is an independent telehealth service; HauteFlair is not responsible for medical outcomes. This article contains affiliate links to ElixMD.